← Back to Search

Antiplatelet Agent

Treatment for Heart Attack (CAMEO Trial)

N/A
Recruiting
Led By Tracy Wang, MD
Research Sponsored by Chiesi USA, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time frame is hospitalization, up to 7 days post discharge
Awards & highlights

Summary

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Eligible Conditions
  • Heart Attack

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time frame is hospitalization, up to 7 days post discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame is hospitalization, up to 7 days post discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of bleeding events during hospitalization as measured by medical record report
The number of Antiplatelet medications used during hospitalization

Find a Location

Who is running the clinical trial?

Duke UniversityOTHER
2,424 Previous Clinical Trials
3,062,084 Total Patients Enrolled
Chiesi USA, Inc.Lead Sponsor
8 Previous Clinical Trials
2,104 Total Patients Enrolled
Tracy Wang, MDPrincipal InvestigatorDuke University
2 Previous Clinical Trials
8,877 Total Patients Enrolled
~67 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top